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Thyroid Hypoplasia as a Cause of Congenital





Rubinstein-Taybi syndrome (RSTS, OMIM 180849) is a
rare condition, inherited in an autosomal dominant fashion and
characterized by short stature, well-established craniofacial
features, moderate to severe motor and intellectual disability,
broad, often angulated thumbs, and enlarged first toes. The
prevalence of RSTS is approximately one per 300 000 persons
and may be as high as one per 1 000 live births (1,2,3,4,5,6).
Most cases of RSTS are sporadic and families with more than
one affected child are extremely rare. Apart from one of the
monozygotic twins reported to date, this syndrome has been
noted as concordant (3). The known genetic causes of RSTS
are point mutations or microdeletions of the response 
element-binding protein-binding protein (CREBBP) gene
encoding cAMP CREBBP, which is localized to 16p13.3 
(50-60%), and of the EP300 gene encoding E1A binding 
protein p300 localized to 22q13.2 (5%) (1,2,3,4,5,6). 
Thyroid dysgenesis (TD) is a common cause of congenital
hypothyroidism (CH), affecting about one in 5 000 live births.
There are several reports of an increased frequency of birth
defects associated with primary CH, but TD is 
generally considered as a nongenetic disease (7,8). Various
endocrinological problems are expected in patients with 
mutations of CREBBP since they disrupt the hormonal 
ABSTRACT
Rubinstein-Taybi syndrome (RSTS), a genetic disorder characterized by
growth retardation, mental deficiency, dysmorphic face, broad thumbs
and large toes, generally affects monozygotic twins concordantly.
Thyroid hypoplasia(TH)is a common cause of congenital hypothyroidism
(CH) and often accompanies dysmorphic syndromes. A pair of female
twins were admitted to our neonatology unit 16 hours after delivery. 
They were born at 35 weeks of gestation. Both twins had an unusual
dysmorphic facial appearance with microcephaly, as well as broad short
thumbs and large toes. Based on the presence of characteristic 
dysmorphic features, the twins were diagnosed as RSTS. Thyroid 
function tests in the first twin revealed the following results: free 
thyroxine (T4) 8.4 pg/mL, thyrotropin (TSH) 4.62 mIU/L, thyroglobulin
(TG) 213.24 ng/mL and a normal level of urinary iodine excretion (UIE).
Thyroid function test results in the second twin in the second week
were: free T4 5.9 pg/mL, TSH 9.02 mIU/L, TG 204.87 ng/mL, and normal
UIE levels. Thyroid volumes were 0.36 mL and 0.31 mL in the first and
second twin, respectively. TH was confirmed by technetium 99 m
pertechnetate thyroid scans in both infants. Thyroid function tests 
normalized with L-thyroxine replacement therapy (10 μg/kg/day) around
the end of the 3rd week of life. The infants were discharged planning
their follow-up by both endocrinology and cardiology units. The rarity of
cases of twins with RSTS (concordant) co-existing with CH led us to
present this report.
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the only endocrinologic problem reported so far in patients
with RSTS in neonatal period is CH without any abnormality in
thyroid structure (10). Two cases of thyroid hypoplasia (TH) or
TD as the cause of CH in monozygotic twin sisters concordant
for RSTS will be presented in this report.    
Case Report
Twin sisters, aged 16 hours, were admitted to our
Neonatology Unit due to respiratory distress. The twins were
born by caesarean section at 35 weeks of gestation. 
They were the third and fourth children of healthy 32-year-old
mother and 34-year-old father. There was no consanguinity
between the parents. The mother had received adequate 
prenatal care, and monochorionic-diamniotic twin pregnancy
was diagnosed in the second trimester of her pregnancy. 
At admission, both twins were cyanotic and tachypneic with
intercostal retractions and grunting respirations. Clinical 
findings improved with administration of nasal continuous
positive airway pressure. The first twin weighed 1900g 
(10-25th centile), measured 43 cm (10-25th centile) in length
and had a head circumference of 29cm (<10th centile).
Anthropometric measurements of the second twin yielded a
birth weight of 1780 g (10-25th centile), length of 42 cm 
(10-25th centile), and head circumference of 28 cm (<10th
centile).  The twins had an unusual dysmorphic facial
appearance with microcephaly, prominent forehead, 
down-slanting palpebral  fissures, epicanthal folds, 
hyperteleorism, beaked nose, broad  nasal  bridge,
hypoplastic  philtrum,  thin upper lip, swollen-thick lower lip
and micrognathia, and a facial expression, which resembled
an excruciating smile (Figure 1). Both sisters also had broad
short thumbs and large toes. Additionally, the second twin
had radial angulation of the distal interphalangeal joint of her
thumbs. Based on the presence of characteristic dysmorphic
facial features, broad thumbs and large toes, the twin sisters
were diagnosed as RSTS.
Laboratory findings including hemoglobin, hematocrit,
serum calcium, phosphorus, alkaline phosphatase, BUN, 
creatinine, electrolytes, blood sugar, ALT, AST, acid-base 
values, and urine analysis were normal. Both twins had the
same blood group [A Rh (-)], consistent with monozygocyty.
Thyroid function test results on day 7 in the first twin were:
free thyroxine (T4) 8.4 pg/mL (normal: 11±3 pg/mL), 
thyrotropin (TSH) 4.62 mIU/L (normal: 3.8±2.3 mU/L), 
thyroglobulin (TG) 213.24 ng/mL (normal: up to 250 ng/mL)
with normal level of urinary iodine excretion (UIE) 30 μg/dL
(normal: higher than 10 μg/dL). At age two weeks, thyroid
function test results in the second twin were: free T4 5.9
pg/mL (normal: 12±3 pg/mL), TSH 9.02 mIU/L (normal:
4.3±1.6 mU/L), TG 204.87 ng/mL (normal: up to 250 ng/mL),
and UIE 40 μg/dL. Thyroid volumes were 0.36 mL and 0.31
mL (0.60±0.07 mL) (11), respectively (Table 1). TH was 
confirmed by technetium 99 m pertechnetate thyroid scans,
and no ectopic tissue was observed in either twin (Figure 2).
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Figure 1. The appearance of the face, the broad, short thumbs and
large toes are characteristic features of the Rubinstein-Taybi 
syndrome. The second twin had angulation of the distal 
interphalangeal joints of the thumbs. (L1-R1 and L2-R2 designate the
left and right hands of first and second twins, respectively)
Figure 2. Thyroid hypoplasia without ectopic tissue was detected by
technetium 99m pertechnetate thyroid scintigraphy in both twinsEchocardiography was performed because of cardiac 
systolic murmur in both infants. Perimembranous ventricular
septal defect (VSD) and patent foramen ovale were found in
the first twin; perimembranous inlet VSD and a mild patent
ductus arteriosus were detected in the second twin. 
Thyroid function tests normalized with L-thyroxine
replacement therapy (10 μg/kg/day) around the end of the 
3rd  week of life. Both infants were discharged and the 
follow-up was provided by both Pediatric Cardiology and
Endocrinology units. The first one died at age 3 months as a
result of aspiration pneumonia. The second twin completed
the postnatal 5 months of life with poor neurological and
somatic development.
Discussion
RSTS is a prototype of diseases with genetic 
heterogeneity. The characteristic craniofacial features of the
syndrome are down-slanting palpebral fissures, columella
extending below the nares, a highly arched palate, and a 
grimacing smile. Additional features of the disorder include
eye abnormalities, heart and kidney defects, dental problems,
and obesity. Prenatal growth is often normal; however, 
postnatal growth rate rapidly declines in the first few months
of life. People with RSTS have an increased risk of developing
benign and malignant tumors, including certain kinds of brain
tumors and hematologic malignancies. The severity of these
signs and symptoms vary among affected individuals 
(1,2,3,4,5,6,12,13,14). In the neonatal period, accompanying
problems include respiratory and feeding difficulties, 
congenital heart defects, seizures and growth retardation.
Individuals with RSTS are easily diagnosed early in life with
their typical stigmata, as was the case in our patient
(6,12,13,14). The severity of influence was concordant in our
patients since they had similar phenotypic findings such as
typical facial appearance, broad thumbs and toes, similar 
cardiologic defects, and a similar thyroid defect. 
CREBBP is a large nuclear protein, which plays an
essential role in controlling cell growth and division, 
prompting cells to mature and assume specialized functions.
It is also important for transcription regulation, chromatin
remodeling, integration of several different signal transduction
pathways including cAMP, nuclear hormone receptors, signal
transducer and activator of transcription (STAT) proteins, and
for activating protein-1. In addition, it has been shown to be a
critical co-activator for thyroid hormone receptors (7,8,9). On
the other hand, the TSH and thyrotropin-releasing hormone
(TRH) genes are positively regulated by cAMP that acts as a
tonic stimulator of these hormone genes. Additionally, TSH
stimulation increases mitotic activity in thyroid cells by raising
the intracellular cAMP (9). Mutations of the CREBBP are
expected to impair the tonic cAMP stimulation of TRH and
TSH. For that reason, the faulty cAMP signaling decreases the
basal TSH secretion and impairs the effects of TSH in thyroid
cells (9). Probably, TH and hypothyroidism in patients with
RSTS can be explained by the above-mentioned defective
mechanism ongoing from intrauterine life.  Additionally, 
this mechanism is expected to cause resistance to thyroid
hormones, and thus it may be associated with 
several features of RSTS, such as mental retardation, growth
retardation and obesity (6,7,13).  
Endocrinologic disorders like premature thelarche (15) and
obesity (13) during childhood or adolescence have been rarely
reported in cases of RSTS, and only one case of CH has been
described as yet (10). Developmental defects of the thyroid
gland, such as absence, small size or unusual location, are 
collectively named TD. Although familial occurrences have
been described, most cases of TD are sporadic and the 
etiology remains unclear (8,16,17). Recently, several gene
defects of transcription factors {such as PAX8, NKX2-1
[encoding thyroid transcription factor (TTF)-1], FOXE1 
(encoding TTF-2), NKX2-5 and thyroid-stimulating hormone
receptor (TSHR)} have been determined among patients with
permanent primary CH (8,16). Interestingly, TD is rarely
observed in both of monozygotic twins. This finding may be
associated with the influence of non-genetic factors (8,16,17).
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Table 1. Results of thyroid function tests and imaging studies in the twins
The first twin   [first week] The second twin [second week]
Results Normal ranges Results Normal ranges
fT4 (pg/mL) 8.4 11±3 5.9 12±3
TSH (mIU/L) 4.62 3.8±2.3 9.02 4.3±1.6
Thyroglobulin (ng/mL) 213.24 up to 250 204.87 up to 250
UIE (μg/dL) 30 higher than 10 40 higher than 10
Ultrasonography (mL) 0.36 0.60±0.07* 0.31 0.60±0.07*
Scintigraphy Hypoplastic thyroid gland with no ectopic thyroid tissue
* normal values were taken from reference 9.
fT4: thyroxine, TSH: thyrotropin, UIE: urinary iodine excretionHowever, our monozygotic twins showed similar clinical 
findings of TD and RSTS. We speculate that this association
may be more frequent in patients with RSTS who have
CREBBP mutations due to the above-mentioned functions of
this large protein.
In conclusion, we presented monozygotic twins with
RSTS co-existing with TD and CH. To our knowledge, this is
the first reported case of RSTS accompanied by CH in
monozygotic twins. Since both disorders are very rare, this
association may have been coincidental. However, we also
considered the possibility that hypothyroidism resulting from
TH might be a component of RSTS.  
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